Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Soft Tissue Esthetic With Autogenous Dentin Chips and Immediate Implantation Versus Conventional Immediate Implantation With Xenograft in Thin Buccal Bone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03544580
Recruitment Status : Completed
First Posted : June 4, 2018
Last Update Posted : April 27, 2021
Sponsor:
Information provided by (Responsible Party):
Cherine Emad Mahmoud Mohamed Hamada, Cairo University

Brief Summary:
After tooth extraction, host bone resorption and atrophy of alveolar ridge may be observed. Bone resorption occurs specially in incisors and premolar area of jaw in region of thin buccal bone that may lead to change in contour. Total clinical bone loss height approximately 2-5 mm at first 6 months may be observed in vertical dimension , after 12 months alveolar ridge may lose up to 50 % of its width.

Condition or disease Intervention/treatment Phase
Crestal Bone Loss Procedure: immediate implant with dentine chips Procedure: conventional immediate implant Not Applicable

Detailed Description:

Recently augmentation with bone grafting became one of the most common techniques surgically ; progressive bone resorption may be prevented by using augmentation procedures with use of graft materials. The gold standard in regenerative procedures is autogenous bone graft because of osteoinduction , osteoconduction and osteointergration properties required in regeneration. In autogenous bone graft there is need for a second surgical site , donor site morbidity and limited availability will lead to challenge for alternative bio-materials.

Extracted healthy non functional teeth from human are considered to be a dental waste all over the world. High proportion of extracted sockets are left untreated for physiological healing. Inadequate or failure of bone healing in sockets has been seen due to absence of bone graft material. Stem cells, matrix , trace metal ions and growth factors are rich in human tooth. Bone and dentin tissue structure are different but ratio of components is similar (mineral 70% , collagen 20% and body fluid 10% by weight). Dentin after demineralization is mainly composed of type 1 collagen 95% and non collagenous proteins as growth factors.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 16 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Soft Tissue Esthetic With Autogenous Dentin Chips and Immediate Implantation Versus Conventional Immediate Implantation With Xenograft in Thin Buccal Bone: (Randomized Controlled Clinical Trial )
Actual Study Start Date : August 1, 2018
Actual Primary Completion Date : October 30, 2019
Actual Study Completion Date : December 30, 2020

Arm Intervention/treatment
Experimental: immediate implant with dentin chips
using the tooth structure presented in socket either as remaining root or as unrestorable tooth structure remove all periodontal ligaments & scraping all enamel & cementum using a stone also to cut it into slices then putting it in acid to demineralize the dentine ; then using a bone mill to transform dentine into small particles or chips to be used in jumping gap between implant & thin buccal bone
Procedure: immediate implant with dentine chips
Using dentin chips
Other Name: Conventional immediate implantation

Active Comparator: immediate implant with xenograft
after surgical removal of entire badly decayed tooth we immediately put implant and in jumping gap we use xenograft
Procedure: conventional immediate implant
using xenograft
Other Name: immediate implantation with xenograft




Primary Outcome Measures :
  1. Soft tissue esthetics [ Time Frame: 12 months ]

    pink esthetic score will be taken by photos from the day of surgery till 12 months postoperatively.

    The PES will evaluate the mesial papilla, distal papilla, curvature of the facial mucosa, level of the facial mucosa, and root convexity/ soft tissue color and texture at the facial aspect of the implant site as five variables. A score of 2, 1, or 0 is assigned to each of five PES parameters. Thus, in case of an implant restoration, a maximum total PES of 10 is possible




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patient related :

    • Patient who only need to restore this single tooth.
    • Good oral hygiene
    • Systemically healthy (free from any systemic diseases)

Site related :

  • Hopeless tooth (nonrestorable, badly broken, endodontically treated) indicated for extraction and immediate implant placement
  • Esthetic area with thin buccal bone
  • Having periapical bone more than 3mm for primary stability

Exclusion Criteria:

  • Patient related :

    • Smokers
    • Pregnant woman

Site related

  • Teeth that have to be extracted due to advanced periodontal bone loss
  • Trauma in aesthetic area
  • Periapical infection.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03544580


Locations
Layout table for location information
Egypt
Cherine Emad Mahmoud Mohamed Hamada
Giza, Egypt, 12566
Sponsors and Collaborators
Cairo University
Layout table for additonal information
Responsible Party: Cherine Emad Mahmoud Mohamed Hamada, principal investigator, Cairo University
ClinicalTrials.gov Identifier: NCT03544580    
Other Study ID Numbers: CEBD-CU-2018-05-01
First Posted: June 4, 2018    Key Record Dates
Last Update Posted: April 27, 2021
Last Verified: April 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Cherine Emad Mahmoud Mohamed Hamada, Cairo University:
dentin
immediate implant
buccal bone resorption
crestal bone loss